Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FPRF2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg, a cystic fibrosis treatment medication. The delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a targeted pharmaceutical procurement without set-aside designation. DMS Pharmaceutical Group leverages its competitive positioning within the federal market to secure contracts meeting Department of Defense healthcare supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders across a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. As a long-standing federal supplier registered in the System for Award Management since 2001, DMS Pharmaceutical Group serves as a critical partner in the Department of Defense's pharmaceutical supply chain, directly distributing prescription medications and pharmacy services to military healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DB25FPRF2?
SPE2DB25FPRF2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FPRF2 worth?
The government has obligated $18,488 on SPE2DB25FPRF2.
Is contract SPE2DB25FPRF2 an order under another contract?
Yes. SPE2DB25FPRF2 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRF2 competed?
The extent of competition for SPE2DB25FPRF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award